Decreased pain responses of C-C chemokine receptor 5 knockout mice to chemical or inflammatory stimuli

Neuropharmacology

Volumn 67, Issue , 2013, Pages 57-65

  Lee, Yong Kyoung ^a   Choi, Dong Young ^a,b   Jung, Yu Yeon ^a   Yun, Young Won ^a   Lee, Beom Jun ^a   Han, Sang Bae ^a   Hong, Jin Tae ^a  

^a Chungbuk National University   (South Korea)

^b Yeungnam University   (South Korea)

Author keywords

C C chemokine receptor 5; Mu opioid receptor; Naloxone; Pain; Periaqueductal gray

Indexed keywords

CHEMOKINE RECEPTOR CCR5; MU OPIATE RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; IMMUNOREACTIVITY; KNOCKOUT MOUSE; MALE; MOUSE; NOCICEPTION; NONHUMAN; PERIAQUEDUCTAL GRAY MATTER; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; RECEPTOR DOWN REGULATION; WILD TYPE;

ANIMALS; INFLAMMATION MEDIATORS; MICE; MICE, 129 STRAIN; MICE, INBRED C57BL; MICE, KNOCKOUT; PAIN; PAIN MEASUREMENT; PERIAQUEDUCTAL GRAY; RECEPTORS, CCR5; RECEPTORS, OPIOID, MU;

EID: 84873403797     PISSN: 00283908     EISSN: 18737064     Source Type: Journal    
DOI: 10.1016/j.neuropharm.2012.10.030     Document Type: Article

References (60)

1. C. Abbadie, J.A. Lindia, A.M. Cumiskey, L.B. Peterson, J.S. Mudgett, E.K. Bayne, J.A. DeMartino, D.E. MacIntyre, and M.J. Forrest Impaired neuropathic pain responses in mice lacking the chemokine receptor CCR2 Proc. Natl. Acad. Sci. U. S. A. 100 2003 7947 7952
2. U. Arvidsson, M. Riedl, S. Chakrabarti, J.H. Lee, A.H. Nakano, R.J. Dado, H.H. Loh, P.Y. Law, M.W. Wessendorf, and R. Elde Distribution and targeting of a mu-opioid receptor (MOR1) in brain and spinal cord J. Neurosci. 15 1995 3328 3341
3. V.C. Asensio, and I.L. Campbell Chemokines in the CNS: plurifunctional mediators in diverse states Trends Neurosci. 22 1999 504 512
4. A. Bajetto, R. Bonavia, S. Barbero, and G. Schettini Characterization of chemokines and their receptors in the central nervous system: physiopathological implications J. Neurochem. 82 2002 1311 1329
5. R. Bandler, and M.T. Shipley Columnar organization in the midbrain periaqueductal gray: modules for emotional expression? Trends Neurosci. 17 1994 379 389
6. N.M. Barbaro Studies of PAG/PVG stimulation for pain relief in humans Prog. Brain Res. 77 1988 165 173
7. K. Benamar, E.B. Geller, and M.W. Adler Elevated level of the proinflammatory chemokine, RANTES/CCL5, in the periaqueductal grey causes hyperalgesia in rats Eur. J. Pharmacol. 592 2008 93 95
8. J.T. Cannon, G.J. Prieto, A. Lee, and J.C. Liebeskind Evidence for opioid and non-opioid forms of stimulation-produced analgesia in the rat Brain Res. 243 1982 315 321
9. C. Chen, J. Li, G. Bot, I. Szabo, T.J. Rogers, and L.Y. Liu-Chen Heterodimerization and cross-desensitization between the mu-opioid receptor and the chemokine CCR5 receptor Eur. J. Pharmacol. 483 2004 175 186
10. Y. Chen, and C. Sommer Activation of the nociceptin opioid system in rat sensory neurons produces antinociceptive effects in inflammatory pain: involvement of inflammatory mediators J. Neurosci. Res. 85 2007 1478 1488
11. C.C. Clayton, M.R. Bruchas, M.L. Lee, and C. Chavkin Phosphorylation of the mu-opioid receptor at tyrosine 166 (Tyr3.51) in the DRY motif reduces agonist efficacy Mol. Pharmacol. 77 2010 339 347
12. K.G. Commons, S.A. Aicher, L.M. Kow, and D.W. Pfaff Presynaptic and postsynaptic relations of mu-opioid receptors to gamma-aminobutyric acid-immunoreactive and medullary-projecting periaqueductal gray neurons J. Comp. Neurol. 419 2000 532 542
13. F.Q. Cunha, and S.H. Ferreira Peripheral hyperalgesic cytokines Adv. Exp. Med. Biol. 521 2003 22 39
14. T.M. Cunha, G.R. Souza, A.C. Domingues, C.M. Lotufo, M.I. Funez, W.A. Verri Jr., F.Q. Cunha, S.H. Ferreira, and E.U. Carreira Stimulation of peripheral Kappa opioid receptors inhibits inflammatory hyperalgesia via activation of the PI3Kgamma/AKT/nNOS/NO signaling pathway Mol. Pain 8 2012 10
15. J.M. Delfs, H. Kong, A. Mestek, Y. Chen, L. Yu, T. Reisine, and M.F. Chesselet Expression of mu opioid receptor mRNA in rat brain: an in situ hybridization study at the single cell level J. Comp. Neurol. 345 1994 46 68
16. D. Filliol, S. Ghozland, J. Chluba, M. Martin, H.W. Matthes, F. Simonin, K. Befort, C. Gaveriaux-Ruff, A. Dierich, M. LeMeur, O. Valverde, R. Maldonado, and B.L. Kieffer Mice deficient for delta- and mu-opioid receptors exhibit opposing alterations of emotional responses Nat. Genet. 25 2000 195 200
17. M.J. Finley, X. Chen, G. Bardi, P. Davey, E.B. Geller, L. Zhang, M.W. Adler, and T.J. Rogers Bi-directional heterologous desensitization between the major HIV-1 co-receptor CXCR4 and the kappa-opioid receptor J. Neuroimmunol. 197 2008 114 123
18. T. Fujioka, E. Purev, and A. Rostami Chemokine mRNA expression in the cauda equina of Lewis rats with experimental allergic neuritis J. Neuroimmunol. 97 1999 51 59
19. C. Gaveriaux-Ruff, L.A. Karchewski, X. Hever, A. Matifas, and B.L. Kieffer Inflammatory pain is enhanced in delta opioid receptor-knockout mice Eur. J. Neurosci. 27 2008 2558 2567
20. H. Jung, P.T. Toth, F.A. White, and R.J. Miller Monocyte chemoattractant protein-1 functions as a neuromodulator in dorsal root ganglia neurons J. Neurochem. 104 2008 254 263
21. B.I. Khalefa, M. Shaqura, M. Al-Khrasani, S. Furst, S.A. Mousa, and M. Schafer Relative contributions of peripheral versus supraspinal or spinal opioid receptors to the antinociception of systemic opioids Eur. J. Pain 16 2012 690 705
22. T.H. Kramer, J.E. Shook, W. Kazmierski, E.A. Ayres, W.S. Wire, V.J. Hruby, and T.F. Burks Novel peptidic mu opioid antagonists: pharmacologic characterization in vitro and in vivo J. Pharmacol. Exp. Ther. 249 1989 544 551
23. S. Kyrkanides, P.M. Fiorentino, J.N. Miller, Y. Gan, Y.C. Lai, S.S. Shaftel, J.E. Puzas, M.G. Piancino, M.K. O'Banion, and R.H. Tallents Amelioration of pain and histopathologic joint abnormalities in the Col1-IL-1βeta(XAT) mouse model of arthritis by intraarticular induction of mu-opioid receptor into the temporomandibular joint Arthritis Rheum. 56 2007 2038 2048
24. D. Labuz, S. Berger, S.A. Mousa, C. Zollner, H.L. Rittner, M.A. Shaqura, T. Segovia-Silvestre, B. Przewlocka, C. Stein, and H. Machelska Peripheral antinociceptive effects of exogenous and immune cell-derived endomorphins in prolonged inflammatory pain J. Neurosci. 26 2006 4350 4358
25. P. Lobmaier, M. Gossop, H. Waal, and J. Bramness The pharmacological treatment of opioid addiction-a clinical perspective Eur. J. Clin. Pharmacol. 66 2010 537 545
26. D.R. Loyd, X. Wang, and A.Z. Murphy Sex differences in micro-opioid receptor expression in the rat midbrain periaqueductal gray are essential for eliciting sex differences in morphine analgesia J. Neurosci. 28 2008 14007 14017
27. Q.P. Ma, and J.S. Han Naloxone blocks the release of opioid peptides in periaqueductal gray and N. accumbens induced by intra-amygdaloid injection of morphine Peptides 12 1991 1235 1238
28. A. Mansour, C.A. Fox, S. Burke, H. Akil, and S.J. Watson Immunohistochemical localization of the cloned mu opioid receptor in the rat CNS J. Chem. Neuroanat. 8 1995 283 305
29. A. Mansour, H. Khachaturian, M.E. Lewis, H. Akil, and S.J. Watson Anatomy of CNS opioid receptors Trends Neurosci. 11 1988 308 314
30. J. Menetski, S. Mistry, M. Lu, J.S. Mudgett, R.M. Ransohoff, J.A. Demartino, D.E. Macintyre, and C. Abbadie Mice overexpressing chemokine ligand 2 (CCL2) in astrocytes display enhanced nociceptive responses Neuroscience 149 2007 706 714
31. P. Menten, A. Wuyts, and J. Van Damme Macrophage inflammatory protein-1 Cytokine Growth Factor Rev. 13 2002 455 481
32. R.J. Miller, and O. Meucci AIDS and the brain: is there a chemokine connection? Trends Neurosci. 22 1999 471 479
33. E. Milligan, V. Zapata, D. Schoeniger, M. Chacur, P. Green, S. Poole, D. Martin, S.F. Maier, and L.R. Watkins An initial investigation of spinal mechanisms underlying pain enhancement induced by fractalkine, a neuronally released chemokine Eur. J. Neurosci. 22 2005 2775 2782
34. E.D. Milligan, V. Zapata, M. Chacur, D. Schoeniger, J. Biedenkapp, K.A. O'Connor, G.M. Verge, G. Chapman, P. Green, A.C. Foster, G.S. Naeve, S.F. Maier, and L.R. Watkins Evidence that exogenous and endogenous fractalkine can induce spinal nociceptive facilitation in rats Eur. J. Neurosci. 20 2004 2294 2302
35. S.B. Oh, P.B. Tran, S.E. Gillard, R.W. Hurley, D.L. Hammond, and R.J. Miller Chemokines and glycoprotein120 produce pain hypersensitivity by directly exciting primary nociceptive neurons J. Neurosci. 21 2001 5027 5035
36. S.S. Padi, X.Q. Shi, Y.Q. Zhao, M.R. Ruff, N. Baichoo, C.B. Pert, and J. Zhang Attenuation of rodent neuropathic pain by an orally active peptide, RAP-103, which potently blocks CCR2- and CCR5-mediated monocyte chemotaxis and inflammation Pain 153 2012 95 106
37. C. Park, J.H. Kim, B.E. Yoon, E.J. Choi, C.J. Lee, and H.S. Shin T-type channels control the opioidergic descending analgesia at the low threshold-spiking GABAergic neurons in the periaqueductal gray Proc. Natl. Acad. Sci. U S A 107 2010 14857 14862
38. C. Pasero, R.C. Manworren, and M. McCaffery PAIN control: IV opioid range orders for acute pain management Am. J. Nurs. 107 2007 52 59 quiz 59-60
39. G.F. Passos, C.P. Figueiredo, R.D. Prediger, P. Pandolfo, F.S. Duarte, R. Medeiros, and J.B. Calixto Role of the macrophage inflammatory protein-1alpha/CC chemokine receptor 5 signaling pathway in the neuroinflammatory response and cognitive deficits induced by beta-amyloid peptide Am. J. Pathol. 175 2009 1586 1597
40. Y. Persidsky, and L. Poluektova Immune privilege and HIV-1 persistence in the CNS Immunol. Rev. 213 2006 180 194
41. A. Pert, and T. Yaksh Sites of morphine induced analgesia in the primate brain: relation to pain pathways Brain Res. 80 1974 135 140
42. W. Puehler, C. Zollner, A. Brack, M.A. Shaqura, H. Krause, M. Schafer, and C. Stein Rapid upregulation of mu opioid receptor mRNA in dorsal root ganglia in response to peripheral inflammation depends on neuronal conduction Neuroscience 129 2004 473 479
43. X. Qin, Y. Wan, and X. Wang CCL2 and CXCL1 trigger calcitonin gene-related peptide release by exciting primary nociceptive neurons J. Neurosci. Res. 82 2005 51 62
44. C. Qiu, I. Sora, K. Ren, G. Uhl, and R. Dubner Enhanced delta-opioid receptor-mediated antinociception in mu-opioid receptor-deficient mice Eur. J. Pharmacol. 387 2000 163 169
45. L.S. Redwine, C.B. Pert, J.D. Rone, R. Nixon, M. Vance, B. Sandler, M.D. Lumpkin, D.J. Dieter, and M.R. Ruff Peptide T blocks GP120/CCR5 chemokine receptor-mediated chemotaxis Clin. Immunol. 93 1999 124 131
46. S. Rosi, C.B. Pert, M.R. Ruff, K. McGann-Gramling, and G.L. Wenk Chemokine receptor 5 antagonist D-Ala-peptide T-amide reduces microglia and astrocyte activation within the hippocampus in a neuroinflammatory rat model of Alzheimer's disease Neuroscience 134 2005 671 676
47. T.L. Sorensen, M. Tani, J. Jensen, V. Pierce, C. Lucchinetti, V.A. Folcik, S. Qin, J. Rottman, F. Sellebjerg, R.M. Strieter, J.L. Frederiksen, and R.M. Ransohoff Expression of specific chemokines and chemokine receptors in the central nervous system of multiple sclerosis patients J. Clin. Invest. 103 1999 807 815
48. C. Stein, M.J. Millan, T.S. Shippenberg, K. Peter, and A. Herz Peripheral opioid receptors mediating antinociception in inflammation. Evidence for involvement of mu, delta and kappa receptors J. Pharmacol. Exp. Ther. 248 1989 1269 1275
49. J.H. Sun, B. Yang, D.F. Donnelly, C. Ma, and R.H. LaMotte MCP-1 enhances excitability of nociceptive neurons in chronically compressed dorsal root ganglia J. Neurophysiol. 96 2006 2189 2199
50. S. Suzuki, L.F. Chuang, P. Yau, R.H. Doi, and R.Y. Chuang Interactions of opioid and chemokine receptors: oligomerization of mu, kappa, and delta with CCR5 on immune cells Exp. Cell. Res. 280 2002 192 200
51. I. Szabo, X.H. Chen, L. Xin, M.W. Adler, O.M. Howard, J.J. Oppenheim, and T.J. Rogers Heterologous desensitization of opioid receptors by chemokines inhibits chemotaxis and enhances the perception of pain Proc. Natl. Acad. Sci. U S A 99 2002 10276 10281
52. M.F. Tosi Innate immune responses to infection J. Allergy Clin. Immunol. 116 2005 241 249 quiz 250
53. A.M. Trescot, S. Datta, M. Lee, and H. Hansen Opioid pharmacology Pain Physician. 11 2008 S133 S153
54. Y. Tsukahara-Ohsumi, F. Tsuji, M. Niwa, T. Hata, M. Narita, T. Suzuki, M. Sasano, and H. Aono The kappa opioid receptor agonist SA14867 has antinociceptive and weak sedative effects in models of acute and chronic pain Eur. J. Pharmacol. 671 2011 53 60
55. A.L. Vaccarino, and A.J. Kastin Endogenous opiates: 1999 Peptides 21 2000 1975 2034
56. G.M. Verge, E.D. Milligan, S.F. Maier, L.R. Watkins, G.S. Naeve, and A.C. Foster Fractalkine (CX3CL1) and fractalkine receptor (CX3CR1) distribution in spinal cord and dorsal root ganglia under basal and neuropathic pain conditions Eur. J. Neurosci. 20 2004 1150 1160
57. F.A. White, J. Sun, S.M. Waters, C. Ma, D. Ren, M. Ripsch, J. Steflik, D.N. Cortright, R.H. Lamotte, and R.J. Miller Excitatory monocyte chemoattractant protein-1 signaling is up-regulated in sensory neurons after chronic compression of the dorsal root ganglion Proc. Natl. Acad. Sci. U. S. A. 102 2005 14092 14097
58. N. Zhang, S. Inan, A. Cowan, R. Sun, J.M. Wang, T.J. Rogers, M. Caterina, and J.J. Oppenheim A proinflammatory chemokine, CCL3, sensitizes the heat- and capsaicin-gated ion channel TRPV1 Proc. Natl. Acad. Sci. U. S. A. 102 2005 4536 4541
59. N. Zhang, T.J. Rogers, M. Caterina, and J.J. Oppenheim Proinflammatory chemokines, such as C-C chemokine ligand 3, desensitize mu-opioid receptors on dorsal root ganglia neurons J. Immunol. 173 2004 594 599
60. J.K. Zubieta, Y.R. Smith, J.A. Bueller, Y. Xu, M.R. Kilbourn, D.M. Jewett, C.R. Meyer, R.A. Koeppe, and C.S. Stohler Regional mu opioid receptor regulation of sensory and affective dimensions of pain Science 293 2001 311 315